Stocklytics Platform
Asset logo for symbol ROIV
Roivant Sciences Ltd.
ROIV73
$10.89arrow_drop_up0.13%$0.01
High Quality
Asset logo for symbol ROIV
ROIV73

$10.89

arrow_drop_up0.13%
Key Stats
Open$10.83
Prev. Close$10.87
EPS5.54
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range10.79
11.51
52 Week Range8.24
13.05
Ratios
EPS5.54
Fundamentals
Payout Ratio-
Industry average yield3.18%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

ROIV-
US Healthcare Sector-
US Market-
check_circle

ROIV / Market

ROIV exceeded the US Market which returned -0.68% over the last twenty four hours.
warning

ROIV / Healthcare Sector

ROIV lose to the US Healthcare sector which returned 1.01% over the last twenty four hours.

Roivant Sciences Ltd. (ROIV) Statistics

Roivant Sciences Ltd. (ROIV) is a leading biopharmaceutical company that focuses on identifying and developing innovative therapies for unmet medical needs. The company is dedicated to improving the lives of patients by leveraging its deep scientific expertise and unique approach to drug development. Roivant Sciences Ltd. is committed to delivering value to its shareholders and has a strong track record of financial performance.
When it comes to stock statistics, Roivant Sciences Ltd. has been performing well in the market. The stock has shown consistent growth and has outperformed the sector average. Investors have been attracted to the company's strong fundamentals and its potential for future growth. The valuation metrics also indicate that the stock is undervalued, making it an attractive investment opportunity.
add Roivant Sciences Ltd. to watchlist

Keep an eye on Roivant Sciences Ltd.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the operating margin of Roivant Sciences Ltd. (ROIV) stock?

The operating margin for Roivant Sciences Ltd. (ROIV) is -7.45K%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

How much debt does Roivant Sciences Ltd. (ROIV) have?

Roivant Sciences Ltd. (ROIV) has a total debt of $52.71M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$1.92B.
help

How has Roivant Sciences Ltd. (ROIV) stock's performance compared to its sector and the market over the past year?

Over the past year, Roivant Sciences Ltd. (ROIV) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 18.95%, Roivant Sciences Ltd. has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 44.33%, it has fallen short of the market average. This comparison highlights Roivant Sciences Ltd.'s performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Roivant Sciences Ltd. (ROIV) stock?

The PE (Price to Earnings) ratio of Roivant Sciences Ltd. (ROIV) is currently 1.97. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Roivant Sciences Ltd. (ROIV) stock?

The Earnings Per Share (EPS) for Roivant Sciences Ltd. (ROIV), calculated on a diluted basis, is $5.54. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the EBITDA of Roivant Sciences Ltd. (ROIV) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Roivant Sciences Ltd. (ROIV) is -$1.2B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

Take Your Investments to a Whole New Level